Such experiments would provide crucial insights into the molecular mechanisms underlying the immunoregulatory role of GLI1 in BRCA and potentially guide the development of novel immunotherapeutic strategies targeting GLI1. This evidence concerns the gene GLI1 and invasive breast carcinoma.